The percentage of patients who don't initiate a prescribed therapy can vary by therapeutic area, but is substantial in chronic conditions – for example, approximately 40% of autoimmune patients never begin therapy. This tendency has been exacerbated during the COVID-19 pandemic, and now, more than ever, there is a critical need to make it easier for patients to follow the treatment regimens they've been prescribed.

In this webinar, you will learn how Clinical Nurse Educators and remote phlebotomy services help patients start – and stay on – therapy. IQVIA experts will share how in-home phlebotomy services, frequently used in decentralized clinical trials, can be easily deployed to support therapy initiation and maintenance throughout the patient journey.

KEY SPEAKERS

Joe Andrew
VP Business Operations, IQVIA

Robyn Stoy
Director, Patient Engagement, IQVIA

Nick Strickland
Laboratory Director, Patient Support, IQVIA